Minister says early industry participation can make technologies market-ready (See 'Corp Brief') Dynamic Local Level Planning imperative for documenting Local Biodiversity: Yadav (See 'Corp Brief') National Zoological Park Organises Sunday Bird, Butterfly and Dragonfly Walks to Promote Science (See 'Corp Brief') SEBI - Writ court's intervention is required in a private contractual dispute between petitioner & broker where any contractual or statutory remedies available under SEBI Act is not invoked: HC (See 'Legal Desk') 1st Batch of Corporate Mitra Course Commences with 2879 Learners registered (See 'Corp Brief') SAIL posts strong sales and production growth in August 2026 (See 'Corp Brief') MoS felicitates 'Team India School Children' for Historic Best-Ever Performance (See 'Corp Brief') Coal India Output and Dispatch Set to Accelerate as Monsoon Effect Wanes (See 'Corp Brief') SEBI - Any notice or assessment order is invalid where passed in respect of an entity that has been struck off Register of Companies & has since been dissolved: SEBI (See 'Legal Desk') MoS launches BIO-NIVESH to Catalyse Investment and Scale-Up of Biotechnology Innovations (See 'Corp Brief') NTPC Electron Quiz 2026-27 to be held in Mumbai (See 'Corp Brief') SUMAN Roadmap 2030 focuses on 13 High-Focus States to reduce Maternal and Newborn Deaths (See 'Corp Brief') Media Registration Open for SEMICON India 2026 (See 'Corp Brief') CCI directs IDBI Trusteeship, Axis Trustee and SBI CAP Trustee to cease and desist from anti-competitive conduct (See 'Corp Brief') Environment Minister reviews Coordinated Efforts by NCR States to tackle Air Pollution (See 'Corp Brief') CPC - Objection regarding pecuniary jurisdiction cannot be entertained at stage of final arguments when no such objection is raised by defendant at earliest opportunity or before settlement of issues: HC (See 'Legal Desk') Nadda inaugurates Centre for Advanced Bladder Diagnostics (See 'Corp Brief') NIELIT and Intel India launch Agentic AI Skilling Programs (See 'Corp Brief') IBC - IRP has contravened statutory mandate of IBC by omitting to maintain formal minutes of meetings & relying instead on informal email communications & where IRP omits to act strictly as per prior instructions of CoC: IBBI (See 'Legal Desk') BRICS Members reaffirm Commitment for Multilateral Cooperation in Intellectual Property (See 'Corp Brief') Digital India BHASHINI and Kathmandu Univ explore Collaboration in Language AI (See 'Corp Brief') IBCA, ADB sign MoU strengthening collaboration in Landscape Conservation (See 'Corp Brief') EPFO seeks applications from potential beneficiaries (See 'Corp Brief') IPR - For deciding territorial jurisdiction at inception of suit, if plaintiff's pleadings sufficiently allege that defendant has digital presence accessible, suit cannot be summarily thrown out for lack of jurisdiction: HC (See 'Legal Desk') CCI okays acquisition of up to 100% equity of Apollo Fertility & Apollo Specialty by Kids Clinic India (See 'Corp Brief') CCI approves acquisition of Aseem Infra Finance by TPG Nicobar SG (See 'Corp Brief') Ministry of Civil Aviation launches Hub & Spoke International Flight Operations (See 'Corp Brief') CAQM reviews Enforcement Actions (See 'Corp Brief') IBC - Definition of 'associate' u/s 79(2)(g) cannot be expanded beyond its statutory text, and procedural irregularities such as absence of forensic audit do not warrant rejection if no actual prejudice is demonstrated: NCLT (See 'Legal Desk') Wow! 7.8% growth but it also does not reveal many things! (See CORP EINSICHT) India, Germany sign Joint Declaration of Intent on environment conservation (See 'Corp Brief') IBC - If foreign decree from reciprocating territory remains substantially unsatisfied, and judgment debtor and his family exercise pervasive control over multiple business entities, decree holder is entitled to protection of its interest through appropriate security: SC LB (See 'Legal Desk') Advisor to PM reviews Development Initiatives at Belgaria and Karmatand Townships (See 'Corp Brief') Invest in R&D while fostering partnerships to become global enterprises: RM (See 'Corp Brief') SARFAESI - Attachment of entire subject property cannot be sustained in absence of material showing direct nexus between property & investors' funds involved in criminal proceedings: HC (See 'Legal Desk') Ministry of Coal Holds Preparatory Meeting for Special Campaign 6.0, Reaffirms Commitment to Cleanliness and Efficiency (See 'Corp Brief') PBPT - Per Section 2(26), initiating officer must establish that benami amount was either converted into another form or integrated into general business assets of beneficial owner beyond demarcation before attaching substitute properties: Tribunal (See 'Legal Desk') India must build Future-Ready Workforce for a Global Automotive Industry: Kumaraswamy (See 'Corp Brief') Union Minister to launch fisheries Infrastructure projects worth Rs 36.49 Crore (See 'Corp Brief') Nadda reviews Progress of Rural Health Training Centre, Najafgarh (See 'Corp Brief') IPR - If plaintiff holds registered trademark rights and shows prima facie prior adoption and use, defendant's use of identical mark for identical hospitality & restaurant services is sufficient to justify interim injunctive relief: HC (See 'Legal Desk') 4th Indo-German Environment Forum to be held in New Delhi (See 'Corp Brief') ICAR-IIOR to host Industry Interface to Accelerate Commercialization of Oilseed Technologies (See 'Corp Brief') A&C - Arbitral award immune to interference merely because alternative interpretation of facts or contractual terms exists; cannot be quashed where award is plausible, logical & free from patent illegality, perversity, or conflict with public policy: HC (See 'Legal Desk') Manohar Lal directs Fast-track Project Implementation & Strengthening of Swachhata (See 'Corp Brief') MSDE in collaboration with UP Govt organises PM-SETU Industry Conclave in Lucknow (See 'Corp Brief') MoS holds interaction with delegation of Armed Forces HQ Association (See 'Corp Brief') NBA disburses Rs 5.68 Crore in Benefit-Sharing Funds for Biodiversity Conservation (See 'Corp Brief') Commerce Secretary Rajesh Agrawal Leads 4th India-Argentina JTC Meeting (See 'Corp Brief') IBC - Sale certificate issued by liquidator under insolvency proceedings in respect of property sold by public auction is not compulsorily registrable: HC (See 'Legal Desk') CBN seizes 66.80 lakh psychotropic tablets in major inter-state pharmaceutical diversion case (See 'Corp Brief') Acquire knowledge, question injustice through constitutional means: RM tells youth (See 'Corp Brief') Empowering mother can enable early identification of disability in child: MoS (See 'Corp Brief') MoS lays Foundation Stone of PMGSY Roads Worth Rs 1,503 Crore in Jammu (See 'Corp Brief') Companies Act - Corporate name change is merely alteration of MoA that preserves company's continuous legal identity, rights, liabilities & obligations without creating a new entity or dissolving the old one: HC (See 'Legal Desk')

Print

Govt hosts workshop on increasing R&D in pharma-medical tech sector

Published: Mar 13, 2025

By TIOLCorplaws News Service

NEW DELHI, MAR 13, 2025: THE Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, organised a workshop on the Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) Scheme today. The workshop was inaugurated in the presence of the Secretaries of five stakeholder Ministries and Departments of the Government of India, namely, Amit Agrawal, Secretary, Department of Pharmaceuticals; Prof. Abhay Karandikar, Secretary, Department of Science and Technology (DST); S. Krishnan, Secretary, Ministry of Electronics and Information Technology (MeitY); Dr N. Kalaiselvi, Secretary, Department of Scientific and Industrial Research (DSIR) and Director General (DG), Council of Scientific and Industrial Research (CSIR); and Dr Rajiv Bahl, Secretary, Department of Health Research (DHR) and DG, Indian Council for Medical Research (ICMR). The workshop served as a platform for identifying key action points and approaches to further the shared commitment to promote research and development in the pharmaceuticals and medical technologies sector.

Amit Agrawal, Secretary, Department of Pharmaceuticals highlighted the rapid expansion in the sector, underscoring the importance of research and innovation in driving making and innovating in India for India and the world. In this regard, he highlighted that the global share of personalised and precision technology platforms (such as antibody-drug conjugates, bi-specific antibodies, and cell and gene therapy) among the top-100 drugs by value is growing rapidly, from 5% in 2020 to 9% in 2025 and projected to grow to 20% by 2030. He also highlighted the 10 times increase in the number of Indian healthcare and life sciences startups over the last four years, from over 900 in 2020 to more than 10,000 in 2024, as well as the growing pipeline of innovative products of Indian firms.

Amit Agrawal said that the groundwork and the pipeline for projects for the PRIP scheme has been laid through this growing innovation ecosystem of Indian startups and industry, supported by a wide array of initiatives of the scientific Ministries/ Departments. The latter include the clinical trial network created by CSIR under its INTENT initiative; the patenting support available through DST's TIFAC and ICMR's Patent Mitra initiative; the handholding support available to both medical technology and drug innovations through ICMR's MedTech Mitra initiative; the funding support available to startups through Department of Biotechnology's BIRAC, MeitY's TIDE 2.0 and SAMRIDH schemes and DST's Quantum Computing Mission, etc.

Reiterating the Government's commitment to a robust research ecosystem, Amit said that PRIP is a transformative initiative aimed at catalysing innovation, strengthening industry-academia linkages, and positioning India as a global leader in pharmaceutical and MedTech research.

Prof. Abhay Karandikar, Secretary, DST underscored the importance of cutting-edge scientific research in driving advancements in pharmaceuticals and MedTech, reinforcing India's healthcare ecosystem and highlighted the supports available through the extensive incubator and accelerator network of DST.

S. Krishnan, Secretary, MeitY emphasised the transformative potential of digital health, artificial intelligence (AI) and data-driven technologies in drug discovery and medical device development. He highlighted the research strengths of MeitY's organisations, such as Society for Applied Microwave Electronics Engineering and Research (SAMEER), C-DAC and Centre for Materials for Electronics Technology (C-MET).

Dr Rajiv Bahl, Secretary, DHR and DG, ICMR highlighted the critical role of clinical research, indigenous drug development and regulatory advancements in accelerating pharmaceutical innovation. He offered the full support of the ICMR INTENT, MedTech Mitra and Patent Mitra initiatives in taking forward the shared goals of PRIP scheme. He also said that the industry-academia collaborative research window under the scheme could be of considerable help in taking forward the large volume of intramural and extramural research being funded by ICMR to the market with funding from PRIP and industry involvement.

Dr N. Kalaiselvi, Secretary, DSIR and DG, CSIR underscored the need to foster a culture of scientific collaboration between research institutions and industry to ensure the seamless translation of research into commercially viable applications. She highlighted that considerable research done in CSIR labs could be taken to the market through collaboration with industry and funding from PRIP.

The discussions reaffirmed the Government's vision of transforming India into a global hub for research and innovation in pharmaceuticals and medical technology. The workshop featured four dedicated breakout sessions, bringing together over 100 participants from leading scientific departments and premier institutions, including the National Institutes of Pharmaceutical Education and Research, IITs, CSIR labs and organisations of ICMR, MeitY, DST and Department of Bio technology, along with key government enablers for the ecosystem. Key deliberations covered the emerging trends in pharmaceutical and MedTech research, strategies for translating research into commercially viable products, government support mechanisms to accelerate sectoral growth and flexibilities sought to maximise the impact from the PRIP scheme.

All participants were requested to share their suggestions in the Expression of Interest (EoI) form for the PRIP scheme hosted on the website of the Department of Pharmaceuticals, so that these may be taken into account while taking forward the scheme and enabling participants. The EoI would be open till April 7, 2025.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.